Zimbabwe has rejected a major US health deal worth 367 million US dollars (£272m) over five years because of the United States' insistence on sensitive information.
This move became public after a official document from December was disclosed, revealing that President Emmerson Mnangagwa believed the arrangement was "lopsided".
An official spokesman has since stated that the United States was requesting biological samples for scientific study and commercial gain while was not willing to share the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for further talks to secure a agreement agreeable to both sides so the nation's vital HIV programme can be sustained.
Wider Implications
This rejection comes after a comparable situation in Kenya, where a court halted a similar health funding agreement after legal challenges were filed about the safety of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had managed aid for the US government, but Trump argued its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance transparency and accountability.
Based on statements, Sixteen nations in Africa have to date agreed to these new agreements, constituting over $18.3bn in new funding.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership might have yielded extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to share its genetic material and health information for a long time, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that might result from that shared data," Mangwana explained.
"Effectively, our nation would supply the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our population should a new disease outbreak arise."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting systems already established through the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.
"This mechanism is designed to guarantee that when a nation contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We encourage continued discussions with our American counterparts on how subsequent co-operation might be structured in a manner that honours the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but suggested that negotiations need to persist considering much of the country's HIV programmes depended on international support.
"Where technical issues exist, such as those relating to information security or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," it said.
The halted deal underscores the complex debate between accepting crucial foreign assistance and protecting a country's data in an ever more interconnected world.